Skip to content

Stability Studies and Validation (FDA Compounding Conference 2025)


    Our volunteers were unable to capture the video for this session.
    If you have a link to the recording, please let us know: [email protected]


    About:

    Explore recent examples of inspection deficiencies found at outsourcing facilities and testing laboratories under 21 CFR Part 211.166. Learn the do’s and don’ts when using a stability program, either in-house or at a contract laboratory.

    Presenter:

    Sherry (Xiaohui) Shen
    Consumer Safety Officer
    FDA

    Leave a Comment

    Your email address will not be published. Required fields are marked *